Insulet Corporation (PODD) is in Healthcare, Medical Devices, based in United States, listed on NasdaqGS. Market cap 9.33B USD. 52-week range 126.40 to 354.88 USD. Trailing P/E 25.2. Data as of 2026-10-09.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system ...